Get the Stockscreener App
5.3976
3.46%
0.1976
Cytek Biosciences Inc stock is traded at $5.3976, with a volume of 463.42K.
It is up +3.46% in the last 24 hours and up +6.32% over the past month.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
See More
Previous Close:
$5.20
Open:
$5.15
24h Volume:
463.42K
Relative Volume:
0.79
Market Cap:
$699.61M
Revenue:
$193.01M
Net Income/Loss:
$-12.15M
P/E Ratio:
-134.94
EPS:
-0.04
Net Cash Flow:
$454.00K
1W Performance:
+11.85%
1M Performance:
+6.32%
6M Performance:
-13.50%
1Y Performance:
+22.55%
1-Day Range:
$5.115
$5.39
1-Week Range:
$4.77
$5.39
52-Week Range:
$3.80
$9.87
Cytek Biosciences Inc Stock (CTKB) Company Profile
Name
Cytek Biosciences Inc
Sector
Industry
Phone
(877) 922-9835
Address
47215 LAKEVIEW BOULEVARD, FREMONT
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
Cytek Biosciences Inc Stock (CTKB) Latest News
Preview: Cytek Biosciences's Earnings - Benzinga
Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Cytek Biosciences (CTKB) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024 - GlobeNewswire
Cytek® Biosciences automates panel design with new intelligent algorithm - MSN
Layoff Tracker: Dublin-Based CRO With US Offices Signals Upcoming Layoffs - BioSpace
(CTKB) Trading Report - Stock Traders Daily
The Manufacturers Life Insurance Company Purchases 2,460 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Short Interest Up 5.4% in September - MarketBeat
Institutional investors have a lot riding on Cytek Biosciences, Inc. (NASDAQ:CTKB) with 53% ownership - Simply Wall St
What technical indicators reveal about CTKB stock - US Post News
Cytek BioSciences Inc (CTKB) Becoming More Attractive for Investors - Knox Daily
Millennium Management LLC Raises Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Cytek Biosciences (NASDAQ:CTKB) Shares Up 3.6%Still a Buy? - MarketBeat
Analysts review Cytek BioSciences Inc’s rating - Knox Daily
Examining Cytek BioSciences Inc (CTKB) more closely is necessary - US Post News
Quarterly Snapshot: Quick and Current Ratios for Cytek BioSciences Inc (CTKB) - The Dwinnex
When the Price of (CTKB) Talks, People Listen - Stock Traders Daily
Squarepoint Ops LLC Acquires 170,539 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Renaissance Technologies LLC Makes New $1.31 Million Investment in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Algert Global LLC - MarketBeat
Selling Buzz: Cytek BioSciences Inc [CTKB] CHIEF TECHNOLOGY OFFICER Yan Ming sells 20,000 shares of the company – Knox Daily - Knox Daily
Cytek BioSciences Inc (CTKB) can make a big difference with a little luck - SETE News
Stock Performance Spotlight: Cytek BioSciences Inc (CTKB) Ends the Day at 5.24, Down by -2.78 - The Dwinnex
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by Public Sector Pension Investment Board - Defense World
American Century Companies Inc. Increases Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Dark Forest Capital Management LP Purchases 9,711 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Technical analysis of Cytek BioSciences Inc (CTKB) stock chart patterns - US Post News
Deerfield Management Company L.P. Series C Purchases Shares of 155,759 Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Jumia Technologies (NYSE:JMIA) Shares Gap Up to $5.21 - Defense World
Where are the Opportunities in (CTKB) - Stock Traders Daily
Investor’s Delight: Cytek BioSciences Inc (CTKB) Closes Strong at 5.19, Up 1.96 - The Dwinnex
Cytek BioSciences Inc (CTKB)’s stock performance: a year in review - US Post News
Texas Permanent School Fund Corp Sells 12,539 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by Rhumbline Advisers - Defense World
Cytek Biosciences (NASDAQ:CTKB) Shares Down 2.6% - MarketBeat
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) - GlobeNewswire
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe - Yahoo Finance
Single Cell Analysis Market Expansion: Key Research, Trends, and Strategies Powering Growth to $6.9 Billion... - WhaTech
Cytek Biosciences (NASDAQ:CTKB) Trading 5.5% Higher - MarketBeat
Results from Cytek BioSciences Inc (CTKB) show potential - US Post News
Investor’s Toolkit: Key Ratios for Assessing Cytek BioSciences Inc (CTKB)’s Performance - The Dwinnex
Natixis Advisors LLC Makes New Investment in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Bank of New York Mellon Corp Purchases 29,579 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Egle names Detheux chairman - BioCentury
CTKB’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Shares Not Telling The Full Story - Simply Wall St
(CTKB) Technical Pivots with Risk Controls - Stock Traders Daily
Cytek Biosciences (NASDAQ:CTKB) Stock Price Down 3.8% - MarketBeat
CTKB Stock Sees Surge of Approximately 4.97% in Last Five Days - Knox Daily
Cytek Announces Resignation of Chief Operating Officer Chris Williams - GlobeNewswire
Cytek Biosciences Inc Stock (CTKB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cytek Biosciences Inc Stock (CTKB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Apr 09 '24 |
Sale |
7.00 |
1,900 |
13,304 |
6,008,502 |
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Mar 18 '24 |
Sale |
6.77 |
20,000 |
135,400 |
6,030,402 |
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Mar 19 '24 |
Sale |
6.71 |
20,000 |
134,200 |
6,010,402 |
| Jeanmonod Patrik | Chief Financial Officer |
Dec 26 '23 |
Sale |
9.50 |
3,000 |
28,500 |
93,400 |
| Yan Ming | Chief Technology Officer |
Dec 19 '23 |
Sale |
9.43 |
20,000 |
188,600 |
6,042,103 |
| Jeanmonod Patrik | Chief Financial Officer |
Nov 24 '23 |
Sale |
6.94 |
3,000 |
20,820 |
96,400 |
| Yan Ming | Chief Technology Officer |
Nov 20 '23 |
Sale |
6.03 |
20,000 |
120,600 |
7,762,103 |
| Jiang Wenbin | President and CEO |
Nov 07 '23 |
Sale |
4.34 |
20,000 |
86,800 |
5,275,796 |
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):